First Time Loading...

Interpace Biosciences Inc
OTC:IDXG

Watchlist Manager
Interpace Biosciences Inc Logo
Interpace Biosciences Inc
OTC:IDXG
Watchlist
Price: 1.42 USD 2.16%
Updated: May 1, 2024

Interpace Biosciences Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Interpace Biosciences Inc
Revenue Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Interpace Biosciences Inc
OTC:IDXG
Revenue
$38.2m
CAGR 3-Years
12%
CAGR 5-Years
13%
CAGR 10-Years
-13%
DaVita Inc
NYSE:DVA
Revenue
$12.1B
CAGR 3-Years
2%
CAGR 5-Years
1%
CAGR 10-Years
0%
Quest Diagnostics Inc
NYSE:DGX
Revenue
$9.3B
CAGR 3-Years
-4%
CAGR 5-Years
4%
CAGR 10-Years
3%
CVS Health Corp
NYSE:CVS
Revenue
$357.8B
CAGR 3-Years
10%
CAGR 5-Years
13%
CAGR 10-Years
11%
Cigna Corp
NYSE:CI
Revenue
$195.3B
CAGR 3-Years
7%
CAGR 5-Years
32%
CAGR 10-Years
20%
Laboratory Corporation of America Holdings
NYSE:LH
Revenue
$12.3B
CAGR 3-Years
-7%
CAGR 5-Years
2%
CAGR 10-Years
8%

See Also

What is Interpace Biosciences Inc's Revenue?
Revenue
38.2m USD

Based on the financial report for Sep 30, 2023, Interpace Biosciences Inc's Revenue amounts to 38.2m USD.

What is Interpace Biosciences Inc's Revenue growth rate?
Revenue CAGR 10Y
-13%

Over the last year, the Revenue growth was 17%. The average annual Revenue growth rates for Interpace Biosciences Inc have been 12% over the past three years , 13% over the past five years , and -13% over the past ten years .